154 related articles for article (PubMed ID: 33848780)
21. Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas.
Lu CF; Hsu FT; Hsieh KL; Kao YJ; Cheng SJ; Hsu JB; Tsai PH; Chen RJ; Huang CC; Yen Y; Chen CY
Clin Cancer Res; 2018 Sep; 24(18):4429-4436. PubMed ID: 29789422
[No Abstract] [Full Text] [Related]
22. Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion.
Li Y; Ammari S; Lawrance L; Quillent A; Assi T; Lassau N; Chouzenoux E
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406550
[TBL] [Abstract][Full Text] [Related]
23. Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
Kihira S; Derakhshani A; Leung M; Mahmoudi K; Bauer A; Zhang H; Polson J; Arnold C; Tsankova NM; Hormigo A; Salehi B; Pham N; Ellingson BM; Cloughesy TF; Nael K
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831380
[TBL] [Abstract][Full Text] [Related]
24. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in
Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH
AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071
[TBL] [Abstract][Full Text] [Related]
25.
Cicone F; Carideo L; Scaringi C; Arcella A; Giangaspero F; Scopinaro F; Minniti G
Ann Nucl Med; 2019 Apr; 33(4):295-302. PubMed ID: 30607877
[TBL] [Abstract][Full Text] [Related]
26. MRI and CT Identify Isocitrate Dehydrogenase
Patel SH; Batchala PP; Mrachek EKS; Lopes MS; Schiff D; Fadul CE; Patrie JT; Jain R; Druzgal TJ; Williams ES
Radiology; 2020 Jan; 294(1):160-167. PubMed ID: 31714193
[TBL] [Abstract][Full Text] [Related]
27.
Zhao K; Yu P; Xue Z; Liu J; Yao A; Zhao Y; Yang F; Tian J; Xu B
Acad Radiol; 2020 Jul; 27(7):e159-e167. PubMed ID: 31607471
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
29. Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.
Lam LHT; Do DT; Diep DTN; Nguyet DLN; Truong QD; Tri TT; Thanh HN; Le NQK
NMR Biomed; 2022 Nov; 35(11):e4792. PubMed ID: 35767281
[TBL] [Abstract][Full Text] [Related]
30. Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma.
Decuyper M; Bonte S; Deblaere K; Van Holen R
Comput Med Imaging Graph; 2021 Mar; 88():101831. PubMed ID: 33482430
[TBL] [Abstract][Full Text] [Related]
31. Prediction of
Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
[TBL] [Abstract][Full Text] [Related]
32. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
33. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
Kanazawa T; Minami Y; Takahashi H; Fujiwara H; Toda M; Jinzaki M; Yoshida K; Sasaki H
Neurosurg Rev; 2020 Aug; 43(4):1211-1219. PubMed ID: 31402410
[TBL] [Abstract][Full Text] [Related]
35. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
Yamauchi T; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Kitagawa Y; Kondo E; Tsushita N; Satomi K; Yoshida A; Ichimura K; Narita Y
Brain Tumor Pathol; 2018 Jul; 35(3):148-158. PubMed ID: 29922974
[TBL] [Abstract][Full Text] [Related]
36. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
[TBL] [Abstract][Full Text] [Related]
37. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
Wang K; Wang Y; Fan X; Li Y; Liu X; Wang J; Ai L; Dai J; Jiang T
J Neurooncol; 2018 Feb; 136(3):523-531. PubMed ID: 29230668
[TBL] [Abstract][Full Text] [Related]
38. Static and dynamic
Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
[TBL] [Abstract][Full Text] [Related]
39. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of
Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK
AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]